In the Boardroom
Refine Search
Biotechnology
Clive Dix, a serially successful figure in UK biotech, has been appointed chief executive of UK biotech company C4X Discovery Holdings. 4 May 2016
Biotechnology
US biotech major Biogen has lured Michael Ehlers, a senior vice president at pharma giant Pfizer, as its executive vice president, Research and Development. 27 April 2016
Biotechnology
US biotech major Biogen has recruited former Merck & Co executive Michel Vounatsos as the company’s executive vice president and chief commercial officer, effective April 18, 2016. 30 March 2016
Biotechnology
The chief executive of GenSpera, a US biotech company, has resigned. 23 March 2016
Biotechnology
Valneva has now established a commercial operation in the UK. 23 March 2016
Biotechnology
US clinical-stage biotechnology company Rigel Pharmaceuticals has appointed Anne-Marie Duliege as its new chief medical officer, it has been announced. 9 March 2016
Biotechnology
Virginia Jamieson is returning as the chief medical officer of Swiss biotechnology firm Kuros Biosciences, it was announced on Tuesday. 8 March 2016
Biotechnology
Privately-held Swiss biotech firm MaxiVAX SA has appointed Dimitrios Goundis as its chief executive. Dr Goundis joins the company after holding several senior management and R&D positions at The Medicines Company, Speedel and Roche, both in Europe and the USA. 8 February 2016
Biotechnology
Gilead Sciences Inc on Friday said chief operating officer John Milligan will be promoted to chief executive, replacing the current chairman and CEO John Martin who will take on the role of executive chairman, both effective March 10, 2016. 29 January 2016
Biotechnology
UK-based life sciences company Avacta has appointed Philippe Cotrel as chief commercial officer, the company said in an announcement. 26 January 2016
Biotechnology
Privately-held US biotech firm Agilis Biotherapeutics has appointed Christopher Silber as its chief medical officer. 26 January 2016
Biotechnology
Austria-based biotechnology company Themis Bioscience on Tuesday announced the appointment of two new members to leadership roles, Philippe Dro and Christian Mandl. 19 January 2016
Biotechnology
UK biotech firm Centauri Therapeutics said today it has acquired the Alphamer technology for drug discovery and development from Altermune Technologies. 18 January 2016
Biotechnology
Shares in US biotech firm Celgene Corp closed down over 5.5% on Nasdaq Monday after the company named chief operating officer Mark Alles as chief executive effective March 1, and cut its outlook for 2015. 12 January 2016
Biotechnology
Cytos Biotechnology on Friday said the company will be renamed Kuros Biosciences Ltd and that its chief executive Christian Itin will be stepping down from his position. 8 January 2016
Biotechnology
Allogeneic CAR T-cell therapies specialist Cellectis has announced the appointment of Loan Hoang-Sayag to the role of chief medical officer. 8 January 2016
Biotechnology
Genticel on Wednesday named Rémi Palmantier chief scientific officer. 6 January 2016
Biotechnology
KaloBios Pharmaceuticals, which fired its controversial chief executive Martin Shkreli earlier this month, yesterday announced that, on December 28, 2015, the company submitted a request to Nasdaq requesting an appeal of Nasdaq's decision to delist the company's securities. 30 December 2015
Biotechnology
Dutch human gene therapy specialist uniQure NV has named Dan Soland its chief executive officer. He will succeed Jörn Aldag, who will step down from the role he has held since 2009. 21 December 2015
Biotechnology
Life sciences company Avacta has appointed Tony Gardiner as group chief financial officer, it has been announced. 10 December 2015
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze